Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07420907 · ClinicalTrials.gov registry record

Study of the Progression of Chronic Cardiovascular Conditions

A clinical trial of Hypertension and Heart Failure, sponsored by Prolaio.

Recruiting
Registry status
5,000
Enrollment target
1
Study location

NCT07420907 is a study of Hypertension and Heart Failure that is actively recruiting participants, run by Prolaio. The registered enrollment target is 5,000 participants, above the 3,497-participant average among 470 other Hypertension trials with a reported enrollment target (43% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07420907, a study of Hypertension and Heart Failure, is actively recruiting participants, sponsored by Prolaio.

RECRUITING
Registry status
5,000 participants
Enrollment target
1
Study location

Study Summary

This study will collect physiologic data in patients with cardiovascular conditions and observe the natural history of those conditions for research purposes.

Conditions Studied

Hypertension Heart Failure Aortic Stenosis Hypertension (HTN) Cardiovascular Disease (CVD) Hypertrophic Cardiomyopathy Without Obstruction Dilated Cardiomyopathy (DCM) Aortic Stenosis Disease Hypertrophic Cardiomyopathy Patients Hypertrophic Cardiomyopathy, Obstructive

Study Locations (1)

Illinois

  • Prolaio - Chicago

Trial Details

FieldValue
Enrollment Target 5,000 participants
Start Date 2025-10-30
Est. Completion 2030-10

Sponsor

Prolaio

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07420907

The ClinicalTrials.gov registry entry for NCT07420907 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,497-participant average among 470 other Hypertension trials with a reported enrollment target (43% higher). The listed sponsor is Prolaio, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Hypertension appearing as the primary indexed condition, and to 0 interventions.

NCT07420907 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT07420907 about?

NCT07420907 is a clinical study titled "Study of the Progression of Chronic Cardiovascular Conditions". This study will collect physiologic data in patients with cardiovascular conditions and observe the natural history of those conditions for research purposes.

What is the current status of trial NCT07420907?

This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2025-10-30. Estimated completion is 2030-10.

What conditions does trial NCT07420907 study?

This clinical trial studies the following conditions: Hypertension, Heart Failure, Aortic Stenosis, Hypertension (HTN), Cardiovascular Disease (CVD).

Who is sponsoring clinical trial NCT07420907?

This trial is sponsored by Prolaio, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07420907 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hypertension

All registered trials for this condition

Heart Failure

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.